Abreu-GonzalezRGallego-PinazoRAbraldesM, et al. Management of diabetic macular edema patients in clinical practice in Spain. Eur J Ophthalmol2019; 29: 664–672.
2.
KodjikianLBellocqDBandelloF, et al. First-line treatment algorithm and guidelines in center-involving diabetic macular edema. Eur J Ophthalmol2019; 29(6): 573–584.
3.
WhiteNHSunWClearyPA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes2010; 59(5): 1244–1253.
4.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ1998; 317(7160): 703–713.
5.
WellsJAGlassmanARAyalaAR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology2016; 123(6): 1351–1359.
